Syncom Formulation (India) 

₹19.05
35
-₹0.15-0.78%Tuesday 09:59

Statistics

Day High
19.71
Day Low
18.9
52W High
27.49
52W Low
10.21
Volume
4,498,477
Avg. Volume
18,866,095
Mkt Cap
17.91B
P/E Ratio
17.3
Dividend Yield
0.52%
Dividend
0.1

Upcoming

Dividends

0.52%Dividend Yield
Sep 2026
₹0.10
Sep 2022
₹0.03
Oct 2017
₹0.02
Oct 2016
₹0.02
Oct 2015
₹0.02
10Y Growth
17.46%
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

May 27Expected
Q4 2022
Q1 2023
Q3 2023
Q4 2023
Q1 2024
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

15.78%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
6.04BRevenue
953.46MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SYNCOMF.NSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Established in 1985 and based in Indore, India, Syncom Formulations (India) Limited specializes in the development, marketing, and sale of a wide array of finished pharmaceutical products. The company provides an extensive portfolio addressing numerous therapeutic categories, including but not limited to pain relief, infectious diseases, cardiovascular health, mental well-being, respiratory ailments, and nutritional deficiencies, alongside specific treatments for conditions like gout and erectile dysfunction, encompassing both generic and specialized medicines. These medicinal preparations are available in various formats such as tablets, capsules, oral liquids, injectables (both liquid and dry vial), dry syrups, topical ointments, inhalers, and herbal formulations. In addition to its core pharmaceutical business, Syncom Formulations also engages in commodity trading and property leasing. The company serves the domestic Indian market and actively exports its products globally.
Show More
CEO
Ankit Kedarmal Bankda
Employees
998
Country
India
ISIN
INE312C01025

Listings

0 Comments

Share your thoughts

FAQs

What is Syncom Formulation (India) stock price today?▼
The current price of SYNCOMF.NSE is ₹19.05 INR — it has decreased by -0.78% in the past 24 hours. Watch Syncom Formulation (India) stock price performance more closely on the chart.
What is Syncom Formulation (India) stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on NSE (India) exchange Syncom Formulation (India) stocks are traded under the ticker SYNCOMF.NSE.
Is Syncom Formulation (India) stock price growing?▼
SYNCOMF.NSE stock has fallen by -6.3% compared to the previous week, the month change is a -20.49% fall, over the last year Syncom Formulation (India) has showed a +16.3% increase.
What is Syncom Formulation (India) market cap?▼
Today Syncom Formulation (India) has the market capitalization of 17.91B
What is Syncom Formulation (India) revenue for the last year?▼
Syncom Formulation (India) revenue for the last year amounts to 6.04B INR.
What is Syncom Formulation (India) net income for the last year?▼
SYNCOMF.NSE net income for the last year is 953.46M INR.
Does Syncom Formulation (India) pay dividends?▼
Yes, SYNCOMF.NSE dividends are paid annual. The last dividend per share was 0.1 . As of today, Dividend Yield (FWD)% is 0.52%.
How many employees does Syncom Formulation (India) have?▼
As of November 4, 2026, the company has 998 employees.
In which sector is Syncom Formulation (India) located?▼
Syncom Formulation (India) operates in the Health & Wellness sector.
When did Syncom Formulation (India) complete a stock split?▼
The last stock split for Syncom Formulation (India) was on August 19, 2013 with a ratio of 5:2.
Where is Syncom Formulation (India) headquartered?▼
Syncom Formulation (India) is headquartered in Indore, India.